Pioneering a new approach to biological discovery
IPI blends academic exploration with industrial scalability
to tap the full potential of recombinant antibodies.
Our proteins power discovery
IPI is a nonprofit research hybrid that invests in high-throughput technologies and deep protein expertise to bring biological research up to speed.
IPI in brief

Meeting research needs
IPI scientists deploy cutting-edge technologies and techniques, such as antibody engineering and a yeast display library, to tap the full potential of synthetic recombinant antibodies.

Best of both worlds
IPI combines deep academic expertise with industrial scalability, investing in high-throughput technologies and automation to bring biological research up to speed.

Unique business model
IPI is a nonprofit institute with assured funding and the high-caliber expertise to support exploratory protein research.

Cross-disciplinary connections
IPI is poised to elevate life science communities, collaborating with biologists across specialties and training young scientists.
Deborah Moshinsky’s enterprising behind-the-scenes efforts ensure antibody quality
Deborah “Deb” Moshinsky is the type of process-motivated scientist that all labs require — but few are lucky to find. As the Director of Characterization and...
IPI’s Antibodies Roadshow fosters neuroscience collaborations
The Institute for Protein Innovation (IPI) kicked off its inaugural “Antibodies Roadshow” on Saturday, October 5, during the Society for Neuroscience meeting in Chicago. The intimate...
Community validation effort draws inspiration from famed HLDA workshops
The Institute for Protein Innovation (IPI), typically quiet on a Sunday afternoon, buzzed with excitement as dozens of researchers gathered, ready to share new data on...
IPI plasmids offer a build-your-own-antibody tool to protein researchers
True to its mission to accelerate research through the advancement of protein science, the Institute for Protein Innovation (IPI) today released its first plasmids. The move...